247 related articles for article (PubMed ID: 30226575)
1. CDCA3 mediates p21-dependent proliferation by regulating E2F1 expression in colorectal cancer.
Qian W; Zhang Z; Peng W; Li J; Gu Q; Ji D; Wang Q; Zhang Y; Ji B; Wang S; Zhang D; Sun Y
Int J Oncol; 2018 Nov; 53(5):2021-2033. PubMed ID: 30226575
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of cell cycle regulator CDCA3 promotes oral cancer progression by enhancing cell proliferation with prevention of G1 phase arrest.
Uchida F; Uzawa K; Kasamatsu A; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Bukawa H
BMC Cancer; 2012 Jul; 12():321. PubMed ID: 22839099
[TBL] [Abstract][Full Text] [Related]
3. CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.
Zhang Y; Yin W; Cao W; Chen P; Bian L; Ni Q
Oncol Rep; 2019 Apr; 41(4):2471-2481. PubMed ID: 30816466
[TBL] [Abstract][Full Text] [Related]
4. CDCA3 promotes cell proliferation by activating the NF-κB/cyclin D1 signaling pathway in colorectal cancer.
Zhang W; Lu Y; Li X; Zhang J; Zheng L; Zhang W; Lin C; Lin W; Li X
Biochem Biophys Res Commun; 2018 Jun; 500(2):196-203. PubMed ID: 29627567
[TBL] [Abstract][Full Text] [Related]
5. Suppression of CDCA3 inhibits prostate cancer progression via NF‑κB/cyclin D1 signaling inactivation and p21 accumulation.
Gu P; Zhang M; Zhu J; He X; Yang D
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34970697
[TBL] [Abstract][Full Text] [Related]
6. miR-145-5p suppresses proliferation, metastasis and EMT of colorectal cancer by targeting CDCA3.
Chen Q; Zhou L; Ye X; Tao M; Wu J
Pathol Res Pract; 2020 Apr; 216(4):152872. PubMed ID: 32107086
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
[TBL] [Abstract][Full Text] [Related]
8. uc.338 targets p21 and cyclin D1 via PI3K/AKT pathway activation to promote cell proliferation in colorectal cancer.
Zhang Y; Wang S; Qian W; Ji D; Wang Q; Zhang Z; Wang S; Ji B; Fu Z; Sun Y
Oncol Rep; 2018 Aug; 40(2):1119-1128. PubMed ID: 29901203
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of CDC27 inhibits the proliferation of colorectal cancer cells via the accumulation of p21Cip1/Waf1.
Qiu L; Wu J; Pan C; Tan X; Lin J; Liu R; Chen S; Geng R; Huang W
Cell Death Dis; 2016 Jan; 7(1):e2074. PubMed ID: 26821069
[TBL] [Abstract][Full Text] [Related]
10. SETDB1 promotes the progression of colorectal cancer via epigenetically silencing p21 expression.
Cao N; Yu Y; Zhu H; Chen M; Chen P; Zhuo M; Mao Y; Li L; Zhao Q; Wu M; Ye M
Cell Death Dis; 2020 May; 11(5):351. PubMed ID: 32393761
[TBL] [Abstract][Full Text] [Related]
11. The long noncoding RNA HOXA transcript at the distal tip promotes colorectal cancer growth partially via silencing of p21 expression.
Lian Y; Ding J; Zhang Z; Shi Y; Zhu Y; Li J; Peng P; Wang J; Fan Y; De W; Wang K
Tumour Biol; 2016 Jun; 37(6):7431-40. PubMed ID: 26678886
[TBL] [Abstract][Full Text] [Related]
12. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of minichromosome maintenance 3 indicates poor outcomes and promotes G1/S cell cycle progression, proliferation, migration and invasion in colorectal cancer.
Zhou H; Xiong Y; Zhang G; Liu Z; Li L; Hou S; Zhou T
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32597491
[TBL] [Abstract][Full Text] [Related]
14. EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling.
Chen JF; Luo X; Xiang LS; Li HT; Zha L; Li N; He JM; Xie GF; Xie X; Liang HJ
Oncotarget; 2016 Jul; 7(27):41540-41558. PubMed ID: 27172794
[TBL] [Abstract][Full Text] [Related]
15. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
[TBL] [Abstract][Full Text] [Related]
16. Down-Regulated LncRNA-HOTAIR Suppressed Colorectal Cancer Cell Proliferation, Invasion, and Migration by Mediating p21.
Lin K; Jiang H; Zhang LL; Jiang Y; Yang YX; Qiu GD; She YQ; Zheng JT; Chen C; Fang L; Zhang SY
Dig Dis Sci; 2018 Sep; 63(9):2320-2331. PubMed ID: 29808247
[TBL] [Abstract][Full Text] [Related]
17. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
[TBL] [Abstract][Full Text] [Related]
18. Hsa_circ_0014717 is downregulated in colorectal cancer and inhibits tumor growth by promoting p16 expression.
Wang F; Wang J; Cao X; Xu L; Chen L
Biomed Pharmacother; 2018 Feb; 98():775-782. PubMed ID: 29571246
[TBL] [Abstract][Full Text] [Related]
19. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
[TBL] [Abstract][Full Text] [Related]
20. The role of E26 transformation-specific variant transcription factor 5 in colorectal cancer cell proliferation and cell cycle progression.
Peng Y; Feng H; Wang C; Song Z; Zhang Y; Liu K; Cheng X; Zhao R
Cell Death Dis; 2021 Apr; 12(5):427. PubMed ID: 33931578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
